Contact Us
Aptitude Health
  • About Us
  • Axess Network
    • Life Science Companies
    • Healthcare Professionals
  • Solutions
    • Business Intelligence
    • Medical Communications
    • Medical Publications
    • Real-World Evidence
    • Promotional Services
    • Case Studies
  • Insight Reports
  • News & Events
  • Log In
    • Axess Network Members
  • Contact Us

NEWS & EVENTS

View All
View All Sign Up

Therapeutic Area

  • Acute Lymphoblastic Leukemia (ALL) (10)
  • Acute Myeloid Leukemia (AML) (14)
  • Advanced Endometrial Cancer (aEC) (2)
  • B-Cell Lymphomas (1)
  • Basal Cell Carcinoma (1)
  • Biliary tract cancer (1)
  • Biliary tract carcinoma (1)
  • Bladder Cancer (4)
  • Bone Cancer (1)
  • Brain Metastases (2)
  • Breast Cancer (44)
  • CAR T (7)
  • Castleman Disease (1)
  • Cervical Cancer (9)
  • Chronic Lymphocytic Leukemia (CLL) (11)
  • Chronic Myeloid Leukemia (CML) (3)
  • Classical Hodgkin Lymphoma (CHL) (1)
  • Colorectal Cancer (11)
  • CRC Malignancies (4)
  • Cutaneous T-cell lymphoma (CTCL) (1)
  • Differentiated Thyroid Cancer (DTC) (1)
  • DLBCL (6)
  • Endometrial Cancer (5)
  • Esophageal squamous cell carcinoma (1)
  • Follicular lymphoma (4)
  • Gastric Cancers (1)
  • Gastrointestinal Malignancies (GI) (17)
  • Genitourinary Malignancies (GU) (20)
  • Glioma (2)
  • Gynecologic Malignancies (10)
  • Head & Neck (3)
  • Hematologic Malignancies (1)
  • Hepatocellular carcinoma (HCC) (6)
  • Hodgkin Lymphoma (5)
  • Leukemia (13)
  • Lung Cancer (19)
  • Lymphoma (15)
  • Maintenance Therapy in Acute Myeloid Leukemia (AML) (1)
  • Management of TKI Therapies (2)
  • Mantle Cell Lymphoma (MCL) (4)
  • Marginal Zone Lymphoma (MZL) (1)
  • Melanoma (12)
  • Merkel cell carcinoma (2)
  • Metastatic cancers (1)
  • Multiple Myeloma (22)
  • Myelodysplastic syndromes (2)
  • Myelodysplastic Syndromes (MDS) (9)
  • Myelofibrosis (MF) (5)
  • Myeloproliferative Neoplasms (MPN) (1)
  • Neuroendocrine Tumors (NET) (1)
  • Non-Hodgkin Lymphoma (3)
  • Non-Small-Cell Lung Carcinoma (NSCLC) (22)
  • NTRK Fusion-Positive Cancers (1)
  • Ovarian Cancer (13)
  • Pancreatic Cancer (3)
  • Ph+ ALL (1)
  • Prostate Cancer (13)
  • Renal cell cancer (RCC) (7)
  • Small Lymphocytic Lymphoma (SLL) (2)
  • Small-cell carcinoma (SCLC) (6)
  • Squamous Cell Carcinoma (2)
  • Thyroid Cancer (5)
  • Urothelial Cancer (2)
  • Urothelial carcinoma (5)
  • Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD/SOS) (2)

Categories

  • Medical Advances (176)
  • Industry Insights (90)
  • Expert Perspectives (21)
  • Aptitude Health (11)

Archives

  • May 2025 (1)
  • April 2025 (3)
  • March 2025 (3)
  • February 2025 (7)
  • January 2025 (1)
  • December 2024 (3)
  • November 2024 (3)
  • October 2024 (2)
  • September 2024 (4)
  • August 2024 (3)
  • July 2024 (3)
  • June 2024 (3)
  • May 2024 (2)
  • April 2024 (3)
  • March 2024 (4)
  • February 2024 (3)
  • January 2024 (3)
  • December 2023 (3)
  • November 2023 (3)
  • October 2023 (3)
Risk for Myeloid Neoplasms After Chimeric Antigen Receptor T-cell Therapy
Medical Advances

Risk for Myeloid Neoplasms After CAR T-Cell Therapy

By Aptitude Health

By Aptitude Health

Aptitude Health logo
Read more
The Net Effect of CAR T-cell Therapy Remains Favorable
Medical Advances

The Net Effect of CAR T-Cell Therapy Remains Favorable

By Aptitude Health

By Aptitude Health

Aptitude Health logo
Read more

Don't Miss Out!

Join thousands of oncology, hematology, and other industry professionals who rely on our monthly newsletter for insights and expert perspectives.

*

Therapeutic Area

  • Acute Lymphoblastic Leukemia (ALL) (10)
  • Acute Myeloid Leukemia (AML) (14)
  • Advanced Endometrial Cancer (aEC) (2)
  • B-Cell Lymphomas (1)
  • Basal Cell Carcinoma (1)
  • Biliary tract cancer (1)
  • Biliary tract carcinoma (1)
  • Bladder Cancer (4)
  • Bone Cancer (1)
  • Brain Metastases (2)
  • Breast Cancer (44)
  • CAR T (7)
  • Castleman Disease (1)
  • Cervical Cancer (9)
  • Chronic Lymphocytic Leukemia (CLL) (11)
  • Chronic Myeloid Leukemia (CML) (3)
  • Classical Hodgkin Lymphoma (CHL) (1)
  • Colorectal Cancer (11)
  • CRC Malignancies (4)
  • Cutaneous T-cell lymphoma (CTCL) (1)
  • Differentiated Thyroid Cancer (DTC) (1)
  • DLBCL (6)
  • Endometrial Cancer (5)
  • Esophageal squamous cell carcinoma (1)
  • Follicular lymphoma (4)
  • Gastric Cancers (1)
  • Gastrointestinal Malignancies (GI) (17)
  • Genitourinary Malignancies (GU) (20)
  • Glioma (2)
  • Gynecologic Malignancies (10)
  • Head & Neck (3)
  • Hematologic Malignancies (1)
  • Hepatocellular carcinoma (HCC) (6)
  • Hodgkin Lymphoma (5)
  • Leukemia (13)
  • Lung Cancer (19)
  • Lymphoma (15)
  • Maintenance Therapy in Acute Myeloid Leukemia (AML) (1)
  • Management of TKI Therapies (2)
  • Mantle Cell Lymphoma (MCL) (4)
  • Marginal Zone Lymphoma (MZL) (1)
  • Melanoma (12)
  • Merkel cell carcinoma (2)
  • Metastatic cancers (1)
  • Multiple Myeloma (22)
  • Myelodysplastic syndromes (2)
  • Myelodysplastic Syndromes (MDS) (9)
  • Myelofibrosis (MF) (5)
  • Myeloproliferative Neoplasms (MPN) (1)
  • Neuroendocrine Tumors (NET) (1)
  • Non-Hodgkin Lymphoma (3)
  • Non-Small-Cell Lung Carcinoma (NSCLC) (22)
  • NTRK Fusion-Positive Cancers (1)
  • Ovarian Cancer (13)
  • Pancreatic Cancer (3)
  • Ph+ ALL (1)
  • Prostate Cancer (13)
  • Renal cell cancer (RCC) (7)
  • Small Lymphocytic Lymphoma (SLL) (2)
  • Small-cell carcinoma (SCLC) (6)
  • Squamous Cell Carcinoma (2)
  • Thyroid Cancer (5)
  • Urothelial Cancer (2)
  • Urothelial carcinoma (5)
  • Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD/SOS) (2)

Categories

  • Medical Advances (176)
  • Industry Insights (90)
  • Expert Perspectives (21)
  • Aptitude Health (11)

Archives

  • May 2025 (1)
  • April 2025 (3)
  • March 2025 (3)
  • February 2025 (7)
  • January 2025 (1)
  • December 2024 (3)
  • November 2024 (3)
  • October 2024 (2)
  • September 2024 (4)
  • August 2024 (3)
  • July 2024 (3)
  • June 2024 (3)
  • May 2024 (2)
  • April 2024 (3)
  • March 2024 (4)
  • February 2024 (3)
  • January 2024 (3)
  • December 2023 (3)
  • November 2023 (3)
  • October 2023 (3)

Don't Miss Out!

Join thousands of oncology, hematology, and other industry professionals who rely on our monthly newsletter for insights and expert perspectives.

*

Aptitude Health

We are the global market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. With a proven track record of success, we transform the world’s growing scientific and clinical knowledge into better patient outcomes. The expertise of our team is backed by unparalleled access to global disease-state experts and healthcare professionals, making Aptitude Health the strategic partner of choice for the world’s most successful life science companies.

United States

5901-B Peachtree Dunwoody Road Suite 415, Atlanta, GA 30328, US
Tel: +1 678 892 1365

Europe

Laan van Nieuw Oost-Indië 133 F, 2593 BM The Hague, the Netherlands
Tel: +31 70 30 67 200

United Kingdom

6th Floor, 2 Kingdom Street London W2 6BD, United Kingdom

About Us
Careers
Axess Network
Life Science Companies
Healthcare Professionals
Solutions
Business Intelligence
Medical Communications
Medical Publications
Real-World Evidence
Promotional Services
Case Studies
Insight Reports
News & Events

Log In
Axess Network Members
Contact Us

Newsletter Signup

Copyright © 2025 Aptitude Health. All Rights Reserved. APTITUDE HEALTH® is a federally registered service mark of Aptitude Health Holdings, LLC.
Terms of Use Privacy Policy Cookie Policy Careers Sitemap
Back To Top

Don't Miss Out!

Join thousands of oncology, hematology, and other industry professionals who rely on our monthly newsletter for insights and expert perspectives.

*

Aptitude Health makes use of cookies to analyze and improve our website user experience and for marketing purposes. By continuing or by clicking on the “Accept” button, you consent to the use of cookies and the processing of personal data obtained in this way. Learn more about our Terms of Use, Cookie Policy, and Privacy Policy.

Aptitude Health
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings. We also use functional cookies to track down misuse of our websites and services, for example by registering the number of consecutive failed login attempts. We do not need your consent for the use of functional cookies, since there is no privacy impact.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics, Vimeo Analytics, and LinkedIn Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy